Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis

BACKGROUND: Achieving a pathological complete response (pCR) is believed to correlate with oncological outcomes in human epidermal growth factor receptor-2-positive (HER2(+)) breast cancer. However, informed estimation of this survival advantage is often difficult to quantify. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Matthew G., Browne, Ferdia, Miller, Nicola, Lowery, Aoife J., Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071230/
https://www.ncbi.nlm.nih.gov/pubmed/35512244
http://dx.doi.org/10.1093/bjsopen/zrac028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071230/
https://www.ncbi.nlm.nih.gov/pubmed/35512244
http://dx.doi.org/10.1093/bjsopen/zrac028

Ejemplares similares